Anna Axelsson Raja1,2, Hoshang Farhad2, Anne Marie Valente3, John-Paul Couce3,4, John Lynn Jefferies5, Henning Bundgaard1, Kenneth Zahka6, Harry Lever6, Anne M Murphy7, Euan Ashley8, Sharlene M Day9, Mark V Sherrid10, Ling Shi11, David A Bluemke12, Charles E Canter13, Steven D Colan3, Carolyn Y Ho2. 1. Rigshospitalet, University of Copenhagen, Denmark (A.A., H.B.). 2. Brigham and Women's Hospital, Boston, MA (A.A., H.F., C.Y.H.). 3. Boston Children's Hospital, MA (A.M.V., J.-P.C., S.D.C.). 4. The present affiliation for J.-P. Couce is the London School of Hygiene and Tropical Medicine. 5. Cincinnati Children's Hospital Medical Center, OH (J.L.J.). 6. Cleveland Clinic, OH (K.Z., H.L.). 7. Johns Hopkins University, Baltimore, MD (A.M.M.). 8. Stanford University School of Medicine, Palo Alto, CA (E.A.). 9. University of Michigan, Ann Arbor (S.M.D.). 10. New York University Langone Medical Center, NY (M.V.S.). 11. New England Research Institutes, Watertown, MA (L.S.). 12. University of Wisconsin, Madison (D.A.B.). 13. Washington University School of Medicine, St. Louis, MO (C.E.C.).
Abstract
BACKGROUND: Late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) is believed to represent dense replacement fibrosis. It is seen in ≈60% of adult patients with hypertrophic cardiomyopathy (HCM). However, the prevalence of LGE in children and adolescents with HCM is not well established. In addition, longitudinal studies describing the development and evolution of LGE in pediatric HCM are lacking. This study assesses the prevalence, progression, and clinical correlations of LGE in children and adolescents with, or genetically predisposed to, HCM. METHODS: CMR scans from 195 patients ≤21 years of age were analyzed in an observational, retrospective study, including 155 patients with overt HCM and 40 sarcomere mutation carriers without left ventricular (LV) hypertrophy. The extent of LGE was quantified by measuring regions with signal intensity >6 SD above nulled remote myocardium. RESULTS: Patients were 14.3±4.5 years of age at baseline and 68% were male. LGE was present in 70 (46%) patients with overt HCM (median extent, 3.3%; interquartile range, 0.8-7.1%), but absent in mutation carriers without LV hypertrophy. Thirty-one patients had >1 CMR (median interval between studies, 2.4 years; interquartile range, 1.5-3.2 years). LGE was detected in 13 patients (42%) at baseline and in 16 patients (52%) at follow-up CMR. The median extent of LGE increased by 2.4 g/y (range, 0-13.2 g/y) from 2.9% (interquartile range, 0.8-3.2%) of LV mass to 4.3% (interquartile range, 2.9-6.8%) ( P=0.02). In addition to LGE, LV mass and left atrial volume, indexed to body surface area, and z score for LV mass, as well, increased significantly from first to most recent CMR. CONCLUSIONS: LGE was present in 46% of children and adolescents with overt HCM, in contrast to ≈60% typically reported in adult HCM. In the subset of patients with serial imaging, statistically significant increases in LGE, LV mass, and left atrial size were detected over 2.5 years, indicating disease progression over time. Further prospective studies are required to confirm these findings and to better understand the clinical implications of LGE in pediatric HCM.
BACKGROUND: Late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) is believed to represent dense replacement fibrosis. It is seen in ≈60% of adult patients with hypertrophic cardiomyopathy (HCM). However, the prevalence of LGE in children and adolescents with HCM is not well established. In addition, longitudinal studies describing the development and evolution of LGE in pediatric HCM are lacking. This study assesses the prevalence, progression, and clinical correlations of LGE in children and adolescents with, or genetically predisposed to, HCM. METHODS: CMR scans from 195 patients ≤21 years of age were analyzed in an observational, retrospective study, including 155 patients with overt HCM and 40 sarcomere mutation carriers without left ventricular (LV) hypertrophy. The extent of LGE was quantified by measuring regions with signal intensity >6 SD above nulled remote myocardium. RESULTS:Patients were 14.3±4.5 years of age at baseline and 68% were male. LGE was present in 70 (46%) patients with overt HCM (median extent, 3.3%; interquartile range, 0.8-7.1%), but absent in mutation carriers without LV hypertrophy. Thirty-one patients had >1 CMR (median interval between studies, 2.4 years; interquartile range, 1.5-3.2 years). LGE was detected in 13 patients (42%) at baseline and in 16 patients (52%) at follow-up CMR. The median extent of LGE increased by 2.4 g/y (range, 0-13.2 g/y) from 2.9% (interquartile range, 0.8-3.2%) of LV mass to 4.3% (interquartile range, 2.9-6.8%) ( P=0.02). In addition to LGE, LV mass and left atrial volume, indexed to body surface area, and z score for LV mass, as well, increased significantly from first to most recent CMR. CONCLUSIONS: LGE was present in 46% of children and adolescents with overt HCM, in contrast to ≈60% typically reported in adult HCM. In the subset of patients with serial imaging, statistically significant increases in LGE, LV mass, and left atrial size were detected over 2.5 years, indicating disease progression over time. Further prospective studies are required to confirm these findings and to better understand the clinical implications of LGE in pediatric HCM.
Entities:
Keywords:
cardiomyopathy, hypertrophic; fibrosis; magnetic resonance imaging; pediatrics; sarcomeres
Authors: Martin S Maron; Evan Appelbaum; Caitlin J Harrigan; Jacki Buros; C Michael Gibson; Connie Hanna; John R Lesser; James E Udelson; Warren J Manning; Barry J Maron Journal: Circ Heart Fail Date: 2008-06-23 Impact factor: 8.790
Authors: Carolyn Y Ho; Sharlene M Day; Steven D Colan; Mark W Russell; Jeffrey A Towbin; Mark V Sherrid; Charles E Canter; John L Jefferies; Anne M Murphy; Allison L Cirino; Theodore P Abraham; Matthew Taylor; Luisa Mestroni; David A Bluemke; Petr Jarolim; Ling Shi; Lynn A Sleeper; Christine E Seidman; E John Orav Journal: JAMA Cardiol Date: 2017-04-01 Impact factor: 14.676
Authors: Carolyn Y Ho; Siddique A Abbasi; Tomas G Neilan; Ravi V Shah; Yucheng Chen; Bobak Heydari; Allison L Cirino; Neal K Lakdawala; E John Orav; Arantxa González; Begoña López; Javier Díez; Michael Jerosch-Herold; Raymond Y Kwong Journal: Circ Cardiovasc Imaging Date: 2013-04-02 Impact factor: 7.792
Authors: Oliver Bruder; Anja Wagner; Christoph J Jensen; Steffen Schneider; Peter Ong; Eva-Maria Kispert; Kai Nassenstein; Thomas Schlosser; Georg V Sabin; Udo Sechtem; Heiko Mahrholdt Journal: J Am Coll Cardiol Date: 2010-06-25 Impact factor: 24.094
Authors: Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron Journal: Circulation Date: 2014-08-05 Impact factor: 29.690
Authors: James C C Moon; Emma Reed; Mary N Sheppard; Andrew G Elkington; Siew Yen Ho; Margaret Burke; Mario Petrou; Dudley J Pennell Journal: J Am Coll Cardiol Date: 2004-06-16 Impact factor: 24.094
Authors: Tevfik F Ismail; Andrew Jabbour; Ankur Gulati; Amy Mallorie; Sadaf Raza; Thomas E Cowling; Bibek Das; Jahanzaib Khwaja; Francisco D Alpendurada; Ricardo Wage; Michael Roughton; William J McKenna; James C Moon; Amanda Varnava; Carl Shakespeare; Martin R Cowie; Stuart A Cook; Perry Elliott; Rory O'Hanlon; Dudley J Pennell; Sanjay K Prasad Journal: Heart Date: 2014-06-24 Impact factor: 5.994
Authors: Anna Wålinder Österberg; Ingegerd Östman-Smith; Robert Jablonowski; Marcus Carlsson; Henrik Green; Cecilia Gunnarsson; Petru Liuba; Eva Fernlund Journal: Pediatr Cardiol Date: 2021-01-30 Impact factor: 1.655
Authors: Anna Axelsson Raja; Hiroko Wakimoto; Daniel M DeLaughter; Daniel Reichart; Joshua Gorham; David A Conner; Mingyue Lun; Clemens K Probst; Norihiko Sakai; Rachel S Knipe; Sydney B Montesi; Barry Shea; Leonard P Adam; Leslie A Leinwand; William Wan; Esther Sue Choi; Eric L Lindberg; Giannino Patone; Michela Noseda; Norbert Hübner; Christine E Seidman; Andrew M Tager; J G Seidman; Carolyn Y Ho Journal: Proc Natl Acad Sci U S A Date: 2022-07-05 Impact factor: 12.779
Authors: Betty Raman; Rina Ariga; Marco Spartera; Sanjay Sivalokanathan; Kenneth Chan; Sairia Dass; Steffen E Petersen; Matthew J Daniels; Jane Francis; Robert Smillie; Adam J Lewandowski; Eric O Ohuma; Christopher Rodgers; Christopher M Kramer; Masliza Mahmod; Hugh Watkins; Stefan Neubauer Journal: Eur Heart J Cardiovasc Imaging Date: 2019-02-01 Impact factor: 6.875